Pacific Biosciences of California, Inc. PACB
2.03 USD -0.06 (-3.11%)
Nov 12, 2026, 12:15 PM EST
1.80 Day range 2.06
1.07 52-week range 3.44
- YTD
- +8.29%
- 1 year
- +16.38%
PACB revenue history
Revenue is income from the company’s ordinary business activities.
160,005,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 160,005,000 | 5,991,000 | 3.89% |
| FY 2024 | 2024-12-31 | 154,014,000 | -46,507,000 | -23.19% |
| FY 2023 | 2023-12-31 | 200,521,000 | 72,217,000 | 56.29% |
| FY 2022 | 2022-12-31 | 128,304,000 | -2,209,000 | -1.69% |
| FY 2021 | 2021-12-31 | 130,513,000 | 51,620,000 | 65.43% |
| FY 2020 | 2020-12-31 | 78,893,000 | -11,998,000 | -13.20% |
| FY 2019 | 2019-12-31 | 90,891,000 | 12,265,000 | 15.60% |
| FY 2018 | 2018-12-31 | 78,626,000 | -14,842,000 | -15.88% |
| FY 2017 | 2017-12-31 | 93,468,000 | 2,754,000 | 3.04% |
| FY 2016 | 2016-12-31 | 90,714,000 | -2,068,000 | -2.23% |
| FY 2015 | 2015-12-31 | 92,782,000 | 32,188,000 | 53.12% |
| FY 2014 | 2014-12-31 | 60,594,000 | 32,413,000 | 115.02% |
| FY 2013 | 2013-12-31 | 28,181,000 | 2,198,000 | 8.46% |
| FY 2012 | 2012-12-31 | 25,983,000 | -7,880,000 | -23.27% |
| FY 2011 | 2011-12-31 | 33,863,000 | 32,189,000 | 1922.88% |
| FY 2010 | 2010-12-31 | 1,674,000 | 1,539,000 | 1140.00% |
| FY 2009 | 2009-12-31 | 135,000 | -766,000 | -85.02% |
| FY 2008 | 2008-12-31 | 901,000 | -1,262,000 | -58.34% |
| FY 2007 | 2007-12-31 | 2,163,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:52.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.